Author | Charles Gourley, PhD, MBChB | OncLive

Author | Charles Gourley, PhD, MBChB

Articles

Benefit of Maintenance Olaparib in Patients With Ovarian Cancer

August 25, 2016

Video

Charlie Gourley, PhD, MBChB, chair and honorary consultant in Medical Oncology at Edinburgh Cancer Research Centre in the United Kingdom, discusses a study comparing the use of olaparib (Lynparza) after chemotherapy with placebo after chemotherapy in patients with platinum-sensitive ovarian cancer.

x